Treatment.com AI Medical Education Corporate Update and Updates on Additional Marketing Engagements
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) has provided updates on its marketing engagements and focus on AI in medical education. The company has extended its agreement with Leit Media for investor relations services, adding an additional EUR 250,000 for a digital marketing campaign targeting German-speaking investors. Treatment.com has also engaged Interactive Media Group (IMG) for a one-month marketing awareness program for US$23,000.
The company highlighted the global adoption of the Objective Structured Clinical Examination (OSCE) in over 80 countries, with an estimated 200,000-300,000 medical students taking the exam annually. Treatment.com has been providing OSCE services to medical schools, including the University of Minnesota, for the past three years.
Treatment.com will be a lead participant in an upcoming Symposium on AI Assessment in Medical Education. The company is also on track to release two new SaaS solutions in H2 2024: AI Patient and AI Doctor in a Pocket, aimed at supporting medical students and healthcare professionals.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) ha fornito aggiornamenti sulle sue attività di marketing e sul focus sull'IA nell'istruzione medica. L'azienda ha esteso il suo accordo con Leit Media per i servizi di relazioni con gli investitori, aggiungendo ulteriori 250.000 EUR per una campagna di marketing digitale rivolta agli investitori di lingua tedesca. Treatment.com ha anche ingaggiato l'Interactive Media Group (IMG) per un programma di sensibilizzazione al marketing di un mese per 23.000 USD.
L'azienda ha evidenziato l'adozione globale del Objective Structured Clinical Examination (OSCE) in oltre 80 paesi, con un numero stimato di 200.000-300.000 studenti di medicina che sostengono l'esame ogni anno. Treatment.com ha fornito servizi OSCE alle scuole di medicina, inclusa l'Università del Minnesota, negli ultimi tre anni.
Treatment.com sarà un partecipante principale in un imminente Simposio sulla Valutazione dell'IA nell'Istruzione Medica. L'azienda è anche in procinto di lanciare due nuove soluzioni SaaS nella seconda metà del 2024: AI Patient e AI Doctor in a Pocket, destinate a supportare gli studenti di medicina e i professionisti della salute.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) ha proporcionado actualizaciones sobre sus actividades de marketing y su enfoque en la IA en la educación médica. La empresa ha ampliado su acuerdo con Leit Media para servicios de relaciones con inversores, añadiendo 250.000 EUR para una campaña de marketing digital orientada a inversores de habla alemana. Treatment.com también ha contratado a Interactive Media Group (IMG) para un programa de concienciación de marketing de un mes por 23.000 USD.
La empresa destacó la adopción global del Objective Structured Clinical Examination (OSCE) en más de 80 países, con un estimado de 200.000-300.000 estudiantes de medicina que rinden el examen anualmente. Treatment.com ha estado proporcionando servicios OSCE a escuelas de medicina, incluyendo la Universidad de Minnesota, durante los últimos tres años.
Treatment.com será un participante principal en un próximo Simposio sobre Evaluación de IA en Educación Médica. La empresa también está en camino de lanzar dos nuevas soluciones SaaS en la segunda mitad de 2024: AI Patient y AI Doctor in a Pocket, destinadas a apoyar a estudiantes de medicina y profesionales de la salud.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF)는 마케팅 참여 및 의학 교육에서 AI에 대한 집중에 대한 업데이트를 제공했습니다. 이 회사는 Leit Media와의 계약을 연장하여 독일어를 사용하는 투자자를 목표로 하는 디지털 마케팅 캠페인에 추가로 250,000 유로를 할당했습니다. Treatment.com은 또한 Interactive Media Group (IMG)와 함께 23,000 USD를 들여 한 달간의 마케팅 인지도 프로그램을 진행합니다.
회사는 80개 이상 국가에서 Objective Structured Clinical Examination (OSCE)의 글로벌 채택을 강조했으며, 매년 약 200,000-300,000명의 의대생이 이 시험을 치릅니다. Treatment.com은 지난 3년 동안 미네소타 대학교를 포함한 의과 대학에 OSCE 서비스를 제공해왔습니다.
Treatment.com은 의학 교육에서 AI 평가에 관한 다가오는 심포지엄의 주요 참여자가 될 것입니다. 이 회사는 또한 2024년 하반기에 의대생과 의료 전문가를 지원하기 위한 두 개의 새로운 SaaS 솔루션인 AI Patient와 AI Doctor in a Pocket을 출시할 예정입니다.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) a fourni des mises à jour sur ses engagements marketing et son focus sur l'IA dans l'éducation médicale. L'entreprise a prolongé son accord avec Leit Media pour des services de relations investisseurs, ajoutant un montant supplémentaire de 250 000 EUR pour une campagne de marketing numérique ciblant les investisseurs germanophones. Treatment.com a également engagé le groupe Interactive Media (IMG) pour un programme d'engagement marketing d'un mois d'une valeur de 23 000 USD.
L'entreprise a souligné l'adoption mondiale de l'Objective Structured Clinical Examination (OSCE) dans plus de 80 pays, avec environ 200 000 à 300 000 étudiants en médecine passant l'examen chaque année. Treatment.com fournit des services OSCE aux écoles de médecine, y compris l'Université du Minnesota, depuis trois ans.
Treatment.com sera un participant principal d'un prochain symposium sur l'évaluation de l'IA dans l'éducation médicale. L'entreprise est également sur la bonne voie pour lancer deux nouvelles solutions SaaS au second semestre 2024 : AI Patient et AI Doctor in a Pocket, destinées à soutenir les étudiants en médecine et les professionnels de santé.
Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF) hat Aktualisierungen zu seinen Marketingaktivitäten und dem Fokus auf KI in der medizinischen Ausbildung gegeben. Das Unternehmen hat seine Vereinbarung mit Leit Media verlängert und zusätzlich 250.000 EUR für eine digitale Marketingkampagne bereitgestellt, die sich an deutschsprachige Investoren richtet. Treatment.com hat auch Interactive Media Group (IMG) für ein einmonatiges Marketingbewusstseinsprogramm für 23.000 USD engagiert.
Das Unternehmen hob die globale Verbreitung des Objective Structured Clinical Examination (OSCE) in über 80 Ländern hervor, mit geschätzten 200.000-300.000 Medizinstudenten, die jährlich die Prüfung ablegen. Treatment.com hat in den letzten drei Jahren OSCE-Dienste für medizinische Fakultäten, einschließlich der University of Minnesota, bereitgestellt.
Treatment.com wird ein führender Teilnehmer an einem bevorstehenden Symposium zur KI-Bewertung in der medizinischen Ausbildung sein. Das Unternehmen plant auch, in der zweiten Hälfte des Jahres 2024 zwei neue SaaS-Lösungen herauszubringen: AI Patient und AI Doctor in a Pocket, die darauf abzielen, Medizinstudenten und Gesundheitsfachkräfte zu unterstützen.
- Extended marketing agreement with Leit Media , increasing investment in German-speaking investor outreach
- Engaged Interactive Media Group for additional marketing awareness program
- Providing OSCE services to medical schools for the past three years
- Lead participant in upcoming Symposium on AI Assessment in Medical Education
- On track to release two new SaaS solutions (AI Patient and AI Doctor in a Pocket) in H2 2024
- None.
- OSCE (Objective Structured Clinical Examination) now adopted in over 80 countries and with upwards of 200k students annually
- Lead commercial participant at Global/North American Symposium on AI Assessment in Medical Education AI Assessment in Medical Education Symposium
- New solutions on track for H2 2024 (AI Patient/Doctor in Pocket)
VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to provide marketing updates and a general corporate update on its focus on the utilization of AI within the medical education sector.
Marketing Updates
The Company announces that further to its news releases of July 2nd, September 5th, and 17th, 2024, the Company provides the following additional information required by Canadian Securities Exchange Policy 7 regarding its marketing engagements of Leit Media Ltd. (“Leit”) and Interactive Media Group. (“IMG”).
Leit:
On July 2, 2024, the Company announced that it had engaged Leit, to provide, news release translation, investor relations and email marketing services with a focus on the German stock market and the German-speaking investor community for an initial period of six months commencing July 1, 2024 and ending on January 1, 2025, in consideration of EUR 250,000, and pursuant to an agreement dated July 1, 2024. Leit does not currently own any interest, directly or indirectly, in the Company or its securities. Leit’s address is Flat 285, 61 Praed St., London, W2 1NS, United Kingdom (phone: 44-20-3883-9398, email: office@leit.media). Consideration offered to Leit does not include any securities of the Company, including options. Leit and its directors and officers are arm’s length from the Company.
On September 5, 2024, the Company announced that it has amended the marketing/investor relations agreement with Leit, as previously announced by the Company on July 2, 2024. Pursuant to the amended agreement, the Company will provide an additional amount of EUR 250,000 to Leit for the digital marketing campaign and the campaign will continue to focus on the German speaking investor community. The campaign shall still run from July 1, 2024 to Januarty 1, 2025. Leit will also translate the Company’s news releases into German.
IMG:
On September 17, 2024, the Company announced that it has engaged IMG to conduct a marketing awareness program for the Company for a period of one (1) month commencing on September 24, 2024 and ending on October 24, 2024, in consideration of a payment of US
Market Background – Medical Education
It is estimated that over 80 countries globally have now adopted the OSCE (Objective Structured Clinical Examination) for assessing the practical clinical skills of medical students. These include the United States; United Kingdom; Canada; Australia and New Zealand; Europe (e.g., Ireland, Germany, Netherlands); Middle East (e.g. Saudi Arabia and the UAE) and Asia (e.g. India, China, Japan, and Malaysia). It is estimated that between 200,000 and 300,000 medical students globally take the OSCE exam each year, as derived from indicative numbers of students from key professional bodies including: https://www.aamc.org/; https://www.uems.eu/; https://www.nmc.org.in/; Education - GMC (gmc-uk.org)
For the past 3 years, Treatment has provided OSCE services to Medical Schools, including the University of Minnesota. The service comprises of using our Global Library of Medicine platform (GLM) in (i) creating cases for the OSCE exams (ii) producing scripts for the actors playing the role of patients (iii) scoring the exams with our proprietary automated marking platform and (iv) providing instant results to both faculty and students, as well as offering student enrichment plans.
Upcoming Symposium on AI Assessment in Medical Education
To further underscore its commitment to supporting the next generation of healthcare professionals, Treatment will be a lead participant in an upcoming Symposium on AI Assessment in Medical Education AI Assessment in Medical Education Symposium. The University of Minnesota has confirmed the event will be invitation only, with no media attending. One of the key proponents for advancements in medical education and orchestrators of the Symposium, Dr Claudio Violato comments:
“AI is revolutionizing assessment in medical education by automating grading processes and formative feedback, assessing clinical skills, and diagnosing deficits in learner performance. AI-powered virtual patients offer realistic scenarios for practice, enhancing clinical decision-making skills without risking patient safety.
This landmark symposium will bring experts to the University of Minnesota Medical School on November 1 with a focus on the use of generative AI to produce test questions and clinical assessments; machine scoring and analysis of learner responses to audio-video capture of clinical performance in the workplace (e.g., wards, clinics, etc.); and clinical notes. The symposium will take the next step in the evolution of AI applications to medical education to produce physicians of the highest caliber”. Events | Medical Education Office of Assessment & Evaluation (umn.edu)
Claudio Violato, PhD, Professor and Assistant Dean for Assessment and Evaluation, University of Minnesota Medical Education Office of Assessment and Evaluation
Medical Education Suite (MES) Update
Treatment has worked diligently over the past two quarters to ensure continued evolution of its Medical Education Suite (MES), powered by its Global Library of Medicine (GLM). The company remains on track for release of its previously announced two new monthly subscription-based SaaS solutions for students, residents and all healthcare professionals in the second half of 2024:
- AI Patient – utilizing AI and a library of test cases to further support students in their preparation and readiness for medical multiple-choice questions (MCQ’s) and OSCE exams.
- AI Doctor in a Pocket – delivers a mobile friendly AI powered clinical decision support tool for healthcare professionals and students when they are in clinics, residency or on a hospital ward.
Dr. Essam Hamza, CEO of Treatment.com AI, comments: “We look forward to being the lead commercial participant and showcasing our proprietary MES products at this landmark global symposium”.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment’s GLM platform, through supporting healthcare professionals, allows for the inclusion for disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
FAQ
What new SaaS solutions is Treatment.com AI (TREIF) planning to release in H2 2024?
How many countries have adopted the OSCE exam that Treatment.com AI (TREIF) supports?
What marketing engagements has Treatment.com AI (TREIF) recently announced?
What event will Treatment.com AI (TREIF) be participating in related to AI in medical education?
